Czech Republic’s Pharma & Healthcare Market 2019-2020 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Czech
Republic’s Pharma & Healthcare Market 2019-2020” report has
been added to ResearchAndMarkets.com’s offering.

This report provides a complete and detailed analysis of the healthcare
and pharmaceutical sector for the Czech Republic . The researcher
presents in-depth business intelligence in a standard format across
countries and regions, providing a balanced mix between analysis and
data.

The gross value added (GVA) of the Czech pharmaceutical sector amounted
to CZK 19.4bn in 2017, increasing by a real 11.1% y/y. The sector
accounted for 0.4% of the GDP that year. The pharmaceutical sector
employed 9,855 workers in 2017, accounting for 0.2% of the total number
of employees.

Total healthcare expenditures amounted to CZK 358.8bn in 2017,
increasing by 5.3% y/y, according to OECD data. The increase was mainly
due to public healthcare expenditures, which rose by 4% y/y to CZK
293.3bn, having a share of 81.7% of total healthcare expenditures. Total
healthcare expenditures accounted for 7.1% of GDP in 2017. The human
health and social work activities employed 294,300 people in 2017,
accounting for 7.3% of the total employment in the country.

What this report allows you to do:

• Understand the key elements at play in the healthcare and
  pharmaceutical sector in the Czech Republic
• Access forecasts for growth in the sector
• View key data on healthcare spending and health insurance in the Czech
  Republic
• Crystallise the forces both driving and restraining this sector in the
  Czech Republic
• Build a complete perspective on sector trade, investment and employment
• Understand the competitive landscape and who the major players are
• View M&A activity and major deals
• Gain an understanding of the regulatory environment for the sector in
  the Czech Republic
• Build a clear picture of trends and issues for sub-sectors (medical
  institutions, pharmaceuticals manufacturing and distribution channels)

Key Topics Covered

01 EXECUTIVE SUMMARY

• Sector in Numbers
• Sector Overview
• Sector Snapshot
• Sector Outlook
• Sub-sector Outlook
• Driving Forces
• Restraining Forces

02 SECTOR IN FOCUS

• Main Economic Indicators
• Main Sector Indicators
• Pharmaceutical Output and Gross Value
• Added
• Pharmaceutical Production
• Sales
• New Orders
• Healthcare Expenditure
• Global Positioning
• Regional Positioning
• External Trade
• Foreign Direct Investments
• Employment and Wages

03 COMPETITIVE LANDSCAPE

• Timeline Czech Republic Pharma & Healthcare
• Highlights
• Top 20 Pharmaceutical Companies
• Top M&A Deals
• M&A Activity

04 COMPANIES IN FOCUS

• Teva Pharmaceuticals CR s.r.o.
• Zentiva k.s.
• FARMAK a.s.
• VUAB Pharma a.s.
• Bioveta a.s.

05 REGULATORY ENVIRONMENT

• Key Bodies
• Health Insurance System
• Government Policy VAT Rate
• VAT Rate for Medicines in Europe 2017
• Government Policy

06 HEALTHCARE SERVICES

• Highlights
• Main Events
• Healthcare Expenditures
• Healthcare Insurance Companies
• Life Expectancy
• Disease Trends and Risk Factors
• Number of Hospitals
• Cases of Hospitalisation
• Focus Point – Number of Hospitals by Region
• Number of Hospital Beds
• Focus Point – Number of Beds in Hospitals
• Healthcare Professionals
• Medical Equipment

07 PRESCRIPTION DRUGS

• Highlights
• Prescription Drug Sales
• Patented and Generic Drugs

08 OVER-THE-COUNTER DRUGS

• Highlights
• OTC Drug Sales

09 RETAIL CHANNELS

• Retail

For more information about this report visit https://www.researchandmarkets.com/r/wzqpw5

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related
Topics: Healthcare
Services, Pharmaceuticals